Who
Larry A. Jobe
Director
Company insider
Files Form 4 as: Director, Mannatech; Director, Hilltop Securities Holdings; Director, Us Home Systems.
In numbers
- Trades disclosed
- 159
- Buys
- 29
- Sells
- 7
- Bought
- $1.0M
- Sold
- $284K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 30 Dec 2005
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $12K2,803 at $4.12 | filing |
| 20 May 2026filed 21 May 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $12K2,803 at $4.12 | filing |
| 19 May 2026filed 20 May 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $21K5,000 at $4.20 | filing |
| 19 May 2026filed 20 May 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $21K5,000 at $4.20 | filing |
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 2 Jan 2025filed 6 Jan 2025 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,686 at $14.89 | filing |
| 9 Sep 2024filed 10 Sep 2024 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $126K16,288 at $7.75 | filing |
| 12 Jun 2024filed 14 Jun 2024 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 22 May 2024filed 23 May 2024 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $7,6911,012 at $7.60 | filing |
| 2 Jan 2024filed 5 Jan 2024 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,932 at $8.11 | filing |
| 18 Aug 2023filed 21 Aug 2023 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $16K1,217 at $12.82 | filing |
| 3 Jan 2023filed 5 Jan 2023 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,294 at $17.43 | filing |
| 3 Jan 2022filed 5 Jan 2022 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K1,012 at $39.49 | filing |
| 16 Jun 2021filed 21 Jun 2021 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 23 Mar 2021filed 23 Mar 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $16K898 at $17.50 | filing |
| 4 Jan 2021filed 5 Jan 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K1,873 at $18.68 | filing |
| 2 Jan 2020filed 7 Jan 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K2,229 at $15.70 | filing |
| 2 Jan 2020filed 6 Jan 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K2,201 at $15.90 | filing |
| 17 Jan 2019filed 18 Jan 2019 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $3,446179 at $19.25 | filing |
News
Analyzing Edgewell Personal Care (NYSE:EPC) and Mannatech (NASDAQ:MTEX)MTEX · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Larry A. Jobe; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.